Veru Inc (VERU) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

VERU Veru Inc

Watchlist

0.676
-0.009-1.29%

Close Dec 27 16:00 ET

0.676
0.000-0.01%

Post 20:01 ET

98.93MMarket Cap-2.41P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

H.C. Wainwright Maintains Veru Inc(VERU.US) With Buy Rating, Maintains Target Price $3
Moomoo NewsDec 20 13:31 ET · Ratings
Veru Price Target Maintained With a $3.00/Share by HC Wainwright & Co.
Dow JonesDec 20 07:22 ET · Ratings
Veru Analyst Ratings
BenzingaDec 20 07:10 ET · Ratings
Veru Inc. (VERU) Reports Q4 Loss, Tops Revenue Estimates
Zacks Dec 16 18:20 ET
Veru Inc | 10-K: FY2024 Annual Report
SECDec 16 15:53 ET · Announcements
The Past Three Years for Veru (NASDAQ:VERU) Investors Has Not Been Profitable
Yahoo FinanceDec 11 06:40 ET

Comments

Jaguar8

Nov 5 07:32

NEWS

$Veru Inc (VERU.US)$
Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for Enobosarm to Optimize Weight Loss at ObesityWeek
Veru Inc. presented a meta-analysis of enobosarm's effects on body composition in older obese patients at ObesityWeek 2024. The analysis, based on four previous clinical trials, showed that enobosarm 3mg treatment led to better outcomes compared to placebo. By Day 147, enobosarm-treated subjects showed greater...

Rollercoaster05

Oct 24 14:03

Goooood newsss

$Veru Inc (VERU.US)$
Veru Inc | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.6%)

Jaguar8

Oct 16 07:31

NEWS

$Veru Inc (VERU.US)$
Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the World Obesity and Weight Management Congress
Veru Inc. (NASDAQ: VERU) announced its participation in the World Obesity and Weight Management Congress, scheduled for October 24-26, 2024, in Baltimore, Maryland. The company will deliver a keynote presentation on October 25, 2024, f...

Trytosaveabit

Aug 8 05:34

Make a note! Only ifn you want? Didn’t mean to order you to do something you may not want to? Hehehe

$Veru Inc (VERU.US)$ Veru Inc: Topline Data for Primary Endpoint of Lean Body Mass Expected January 2025

Trytosaveabit

Jun 24 07:40

Update

$Veru Inc (VERU.US)$ Veru Presents Phase 2 and 3 Enobosarm Data At ADA Scientific Sessions: Well-Tolerated With Comparable Adverse Event Profile To Placebo; Effective In Reducing Fat And Preserving Lean Mass In Older Adults And Cancer Patients

Heat List

Overall

No Data